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Background: The cardiotonic pill (CP) is a herbal medicine composed of Salvia miltiorrhiza (SM), Panax notoginseng
(PN), and Dryobalanops aromatica Gaertner (DAG) that is widely used to treat cardiovascular diseases. The present
experiment was conducted to examine the effects of CP on white matter and hippocampal damage induced by
chronic cerebral hypoperfusion.
Methods: Chronic cerebral hypoperfusion was induced in male Wistar rats by permanent bilateral common carotid
artery occlusion (BCCAo). Daily oral administration of CP (200 mg/kg) began 21 days after BCCAo and continued for
42 days. The levels of microglial activation and myelin basic protein (MBP) were measured in the white matter and
hippocampus of rats with chronic BCCAo, and the expression levels of mitogen-activated protein kinases (MAPKs)
and inflammatory markers such as cyclooxygenase-2, interleukin-1β, and interleukin-6 were examined.
Results: MBP expression was reduced in the white matter and hippocampal regions of rats that received BCCAo.
In contrast, reduced levels of MBP were not observed in BCCAo rats given CP treatments. The administration of CP
alleviated microglial activation, the alteration of ERK and p38 MAPK signaling, and inflammatory mediator
expression in rats with chronic BCCAo.
Conclusion: These results suggest that CP may have protective effects against chronic BCCAo-induced white matter
and hippocampal damage by inhibiting inflammatory processes including microglial activation and proinflammatory
mediator expression, and downreguating the hyperphosphorylation of ERK and p38 MAPK signaling.
Keywords: Cardiotonic pill, Permanent bilateral common carotid artery occlusion, Inflammation, Microglia,
White matter, HippocampusBackground
A chronic reduction in cerebral blood flow may lead to
vascular cognitive impairment [1]. Decreased cerebral
blood flow is observed in patients with Alzheimer’s disease
(AD) or vascular dementia (VaD) [2,3]. Rats with chronic
cerebral hypoperfusion induced by permanent bilateral
common carotid artery occlusion (BCCAo) are used to* Correspondence: wkjeon@kiom.re.kr
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reproduction in any medium, provided the orexperimentally study pathological mechanisms and to
develop therapeutic treatments of cognitive impairment in
human vascular disease [4]. Reduced cerebral blood flow
occurs immediately in rats after BCCAo and lasts for
2–3 days. Seven days later, a moderate (20-40%) but per-
sistent reduction in cerebral blood flow remains for se-
veral months [5]. Rats treated with chronic BCCAo
exhibit many features of human VaD and AD [4,5].
One pathological feature in the brains of chronic
BCCAo rats is white matter lesions, which are frequently
observed in the brains of patients with VaD [6]. Chronic. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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naling in brain structures, including the hippocampus
[4,7]. In addition, it has been reported that neuroinflam-
mation is associated with the development of white mat-
ter lesions and hippocampal damage in BCCAo rats
[8,9]. For example, microglial activation is observed in
the white matter and hippocampus. Microglial activation
may aggravate damage to these structures through the
excessive production of reactive oxygen species and pro-
inflammatory cytokines as well as through the activation
of MAPK signaling [4,10,11].
Herbal medicines have traditionally been used to treat
various diseases. Recently, studies have been conducted to
reveal the mechanisms of these medicines and to de-
monstrate the effectiveness of these medicines for other
diseases. One of these herbal medicines is the cardiotonic
pill (CP), which is composed of Salvia miltiorrhiza (SM),
Panax notoginseng (PN), and Dryobalanops aromatica
Gaertner (DAG). This pill has been widely used in Korea,
China, and Russia for the prevention and management of
vascular diseases, such as occlusive vasculitis, coronary
diseases, atherosclerosis, and cerebral infarction [12].
Several studies have demonstrated the protective effects
of CP on ischemia/reperfusion-induced microvascular
dysfunction including myocardial and hepatocellular
injury [12-14].
However, no study has been conducted to demonstrate
the effects of CP on vascular injury-related brain disease.
The goal of the present study was to examine whether
CP treatments ameliorate the brain damage induced by
chronic cerebral hypoperfusion. CP treatments restored
the myelin basic protein (MBP) degradation and microglial
activation in the white matter and hippocampus of chronic
BCCAo rats. The expression levels of inflammatory media-
tors, such as cyclooxygenase-2 (COX-2), interleukin-1 beta
(IL-1β), and interleukin-6 (IL-6), were reduced in the
chronic BCCAo rats given CP treatment versus those
given vehicle treatments. The administration of CP miti-
gated altered mitogen-activated protein kinase (MAPK)
signaling in the hippocampus of chronic BCCAo rats.
Methods
Animals
A total of 55 male Wistar rats were used in the chronic
BCCAo experiment (12 weeks old; Charles River Co.,
Gapeung, South Korea). The rats were housed for two
weeks at the beginning of the experiment in a vivarium at
the Korea Institute of Oriental Medicine under controlled
temperature (22 ± 1°C) and humidity (55 ± 10%) with a
12 h light/dark cycle (lights on at 08:00 h). Food and
water were provided ad libitum to all rats throughout
the experiment. The Institutional Animal Care and Use
Committee of the Korea Institute of Oriental Medicine
approved all protocols described in this report.Animal surgery and drug administration
The Wistar rats were anesthetized with 5% isoflurane in a
70% nitrous oxide and 30% oxygen mixture. Anesthesia
was maintained with 3% isoflurane during the surgical
procedure. A midline incision was made to expose both
common carotid arteries, which were then tightly double-
ligated with silk sutures. Control rats were subjected to
a sham-operation that consisted of the same procedure
without BCCAo. Rectal temperature was maintained at
37.0 ± 0.5°C with a heating pad throughout the surgical
procedure. During hypoperfusion, two rats showed neuro-
logical symptoms, such as seizures with squatting. These
animals died within one week after surgery. In addition,
seven rats that lost 20% or more of their pre-surgical
weight during drug or vehicle administration were ex-
cluded from the present study.
CP was obtained from Sam Chun Dang Pharm. Co.,
Ltd (Seoul, Korea). Each pill contained 17.5 mg of SM,
3.4 mg of PN, and 0.2 mg of DAG. The rats used in the
BCCAo experiment were separated into three groups: a
sham-operated group (oral administration of the drug
vehicle, n = 12), a BCCAo group (oral administration of
the drug vehicle, n = 17), and a BCCAo group that re-
ceived daily oral administration of the drug (200 mg/kg
CP, n = 17). The vehicle/drug treatment was started on
the 20th day after BCCAo surgery and was continued
until the 41st day after first vehicle/drug treatment
(Additional file 1: Figure S1). During drug administra-
tion, the vehicle and CP treatment groups each lost four
rats due to the stress related to long-term oral feeding.
The CP group showed no toxicity in terms of general
behavioral changes or mortality.
Western blot analysis
After the last administration of CP or vehicle, on day 63
after BCCAo surgery (Additional file 1: Figure S1), all of
the rats were decapitated, and their brains were microdis-
sected and then frozen. Tissue homogenates of the hip-
pocampus were prepared, and SDS-polyacrylamide gel
electrophoresis (PAGE) was performed as described pre-
viously [7]. Briefly, individual tissue samples were weighed
and then homogenized in ice-cold RIPA buffer containing
25 mM Tris HCl, pH 7.6, 150 mM NaCl, 1% NP-40,
1% sodium deoxycholate, 0.1% SDS (Thermo Scientific,
Waltham, MA, USA), protease inhibitor cocktail solution
(GenDEPOT, Barker, TX, USA), and phosphatase inhibitor
cocktail solution (GenDEPOT). The homogenates were
then centrifuged at 12,000 × g for 20 min at 4°C, and
the supernatant was harvested, snap-frozen, and stored
at −70°C until use. The protein concentration of the tis-
sue homogenates was determined with the BCA assay
(Thermo Scientific). Equal amounts of protein (40 μg)
were resolved via SDS-PAGE and transferred to polyviny-
lidene difluoride (PVDF) membranes. The membranes
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naling Technology, Beverly, MA, USA), p-p38 MAPK,
p38 MAPK (Cell Signaling), p-JNK, JNK (Cell Signaling),
COX-2 (Santa Cruz Biotechnologies, CA, USA), IL-1β
(Millipore Corporation, Billerica, MA, USA), IL-6 (Abcam,
San Francisco, CA, USA), and GAPDH (Santa Cruz
Biotechnologies). An enhanced chemiluminescence (ECL)
kit (Thermo Scientific) and a Lumino Image Analyzer
(Las-4000; Fujifilm, Tokyo, Japan) were used for detection.
Immunohistochemistry
After undergoing all of the drug administrations, the rats
were euthanized by lethal overdose of Zoletil (50 mg/kg)
and Rompun (5 mg/kg) followed by intracardiac perfusion
with 4% paraformaldehyde. The brains were removed,
postfixed, treated with distilled water containing 30%
sucrose for cryoprotection, snap-frozen, and then cut into
40-μm sections on a freezing microtome. The sections
were blocked overnight at 4°C with a solution of 3% casein
in PBST and incubated with a series of primary antibodies
for 1 h at room temperature. The following primary anti-
bodies were used in the present study: anti-MBP (Abcam),
anti-Iba-1 (Wako, Tokyo Japan), anti-OX-6 (Abcam), and
anti-NeuN (Millipore Corporation). The sections were
washed with PBS three times for 10 min each and then
incubated with the appropriate biotinylated secondary
antibodies (Thermo Scientific) for 2 h and subsequently
with ExtrAvidin peroxidase conjugate (Sigma Aldrich) for
1 h. Finally, the immunostaining was visualized using the
Vector SG substrate kit and the Vector DAB kit (Vector
Laboratories, Burlingame, CA, USA) for peroxidase. The
sections were mounted onto resin-coated slides and
allowed to dry for up to one week. The dried sections on
the slides were coverslipped with Permount reagent.
Statistical analysis
One-way ANOVA was conducted to assess the effects of
CP on changes in the number of OX-6 and Iba-1 posi-
tive cells as well as on the expression levels of MBP,
COX-2, IL-1β, IL-6, and MAPKs induced by chronic
BCCAo. Post-hoc analyses (LSD) were subsequently
conducted to determine the effects of the CP treatment.
P values of less than 0.05 were considered significant
unless otherwise specified. All data are expressed as the
means ± SEM.
Results
CP restored the reduced expression of MBP in the white
matter and hippocampus induced by chronic BCCAo
Chronic cerebral hypoperfusion leads to lesions in the
white matter through the disruption of myelin sheaths
and a loss of oligodendrocytes [15]. MBP is a crucial
component of the myelin sheath. We examined the ef-
fects of CP on chronic BCCAo-induced MBP breakdownin the medial septum, corpus callosum, fimbria, fornix of
the white matter, and hippocampus. An ANOVA revealed
significant group effects in the corpus callosum, fimbria,
fornix, and hippocampus (F(2,11) ≥ 3.79, p < 0.05). Post-
hoc analyses of the group effects revealed that, compared
to the sham-operated control rats, the expression level of
MBP in the BCCAo rats with vehicle treatment was
significantly decreased in white matter regions and the
hippocampus (Figure 1). Interestingly, the reduced level of
MBP was not observed in the chronic BCCAo rats admi-
nistered CP, implying that CP treatment could ameliorate
the degradation of the myelin sheath induced by chronic
cerebral hypoperfusion. An ANOVA for the medial sep-
tum showed no group effects. On the other hand, the grey
matter such as cerebral cortex, which is located near CA1
region of hippocampus vulnerable to chronic cerebral hy-
poperfusion, did not show alteration on MBP expression
(Additional file 2: Figure S2). In addition, neuronal cell
death, determined by counting NeuN-positive cells (neu-
ronal antibody), was observed in CA1, CA3, and DG sub-
fields of the hippocampus of rats with chronic BCCAo
compared to sham-operated control rats. Reversely, this
neuronal cell death was declined in CP-treated chronic
BCCAo rats. However, these findings did not show statis-
tical significance (Additional file 3: Figure S3).
CP inhibited microglial activation in the white matter and
hippocampus induced by chronic BCCAo
To investigate the effect of CP on neuroinflammation
induced by chronic cerebral hypoperfusion, the present
experiment measured the number of Iba-1-positive cells,
the resident microglial cells in the brain, in identical sec-
tions of the corpus callosum, fimbria, optic tract, and
hippocampal subregions (CA1, CA3, and DG) to exa-
mine the effects of CP on BCCAo-induced microglial
activation. An ANOVA revealed significant group effects
of Iba-1-positive cells in the corpus callosum, fimbria, and
hippocampal subregions (CA1, CA3, and DG) (F(2,11) ≥
6.04, p < 0.01). Post-hoc analyses of the group effects
revealed that the number of Iba-1-positive cells in the
vehicle-treated BCCAo rats was significantly higher
than the sham-control rats in all of the regions exa-
mined (Figure 2A through D). CP administration reduced
the increase in Iba-1-positive cells induced by BCCAo in
all of the brain regions examined.
In addition, we measured the number of OX-6-positive
cells, which are activated microglial cells, in the corpus
callosum, fimbria, and optic tract. An ANOVA revealed
significant group effects for OX-6-positive cells in the
corpus callosum, fimbria, and optic tract (F(2,11) ≥ 5.21,
p < 0.05). Post-hoc analyses of the group effects revealed
that the number of OX-6-positive cells in the vehicle-
treated BCCAo rats was significantly higher than in the
sham-control rats in the examined brain regions (Figure 2E
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Figure 1 Effects of CP on the chronic BCCAo-induced MBP reduction in the white matter and hippocampus. Immunohistological staining
was performed to evaluate the expression levels of MBP in the medial septum, corpus callosum, fimbria, fornix, and hippocampus in the sham-control
group (n = 4), BCCAo + Vehicle group (n = 5), and BCCAo + CP group (n = 5). (A) Representative photomicrograph of MBP-positive cells. (B) MBP levels
were decreased in the corpus callosum, fimbria, fornix, and hippocampus of the chronic BCCAo rats compared to control rats (*). Relative to the
chronic BCCAo rats given vehicle, the chronic BCCAo-induced reduction of MBP expression in the CP-treated chronic BCCAo rats was not observed (#).
CC, corpus callosum; HC, hippocampus; LV, lateral ventricle; FI, fimbria; FX, fornix.
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reduction in OX-6-positive cells compared to the BCCAo
rats given the vehicle. The Iba-1 and OX-6 results suggest
that CP treatments mitigated chronic BCCAo-induced
microglial activation in the white matter and hippocampus.
CP attenuated the increase of COX-2, IL-6, and IL-1β
expression in the hippocampus of rat with chronic BCCAo
Activated microglial cells release a variety of proinflamma-
tory cytokines, eventually leading to neuronal injury [16].
Therefore, to examine the effects of CP on BCCAo-
induced inflammation, we used western blotting to mea-
sure hippocampal levels of COX-2, IL-1β, and IL-6. An
ANOVA revealed significant group effects of the measured
proinflammatory markers (F(2,21) ≥ 15.65, p < 0.001). Post-
hoc analyses of the group effects revealed that chronic
BCCAo increased the levels of these proinflammatory
markers in the hippocampus (Figure 3A and B). The in-
crease in proinflammatory markers by chronic BCCAo didnot occur in the chronic BCCAo rats treated with CP
(Figure 3A and B).
CP blocked the hyperphosphorylation of MAPKs in the
hippocampus of rats with chronic BCCAo
To determine the effects of CP on the levels of phos-
phorylated MAPKs induced by chronic BCCAo, we used
western blotting to measure the hippocampal levels of
phosphorylated MAPKs, such as ERK, p38 MAPK, and
JNK. An ANOVA of phosphorylated ERK and p38, but
not of JNK, showed significant group effects (F(2,21) ≥
16.05, p < 0.001). An ANOVA of total ERK, p38, and
JNK showed no group effects. Subsequent post-hoc ana-
lyses showed that the levels of phosphorylated ERK and
p38 were increased in the hippocampus of chronic
BCCAo rats treated with vehicle compared to the sham-
control rats (Figure 4A and B). Increased hippocampal
levels of phosphorylated ERK and p38 MAPKs induced
by chronic BCCAo were not observed in the BCCAo
Figure 2 Effects of CP on the chronic BCCAo-induced microglial activation in the white matter and hippocampus. Immunohistological
staining was conducted to investigate the expression of Iba-1 and OX-6 in regions of the white matter and the hippocampal subregions (CA1, CA3,
and DG), in the sham-control group (n = 4), BCCAo + Vehicle group (n = 5), and BCCAo + CP group (n = 5). (A) Representative photomicrograph of
Iba-1 (A and B) and OX-6 (E and F) positive cells. (B) The number of Iba-1 (C and D) and OX-6 (G and H) positive cells was increased in the chronic
BCCAo rats compared to the sham-control rats (*), an effect that was not observed in the chronic BCCAo rats under CP administration (#).
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results indicate that CP may possess anti-inflammatory
properties through the inhibition of MAPK signaling.
Discussion
A number of studies have demonstrated the beneficial
properties of CP in gut ischemia-reperfusion (I/R)-induced
hepatic microvascular dysfunction and hepatocellular injury[12], thrombus development [17], I/R-induced microcir-
culatory disturbance [14], and myocardial fibrosis [13].
Despite the widespread use of CP for the treatment of car-
diovascular and cerebrovascular diseases, no study has
examined the action of CP upon white matter and hippo-
campal damage by chronic BCCAo. The present study
demonstrates the protective effect of CP against chronic
BCCAo-induced brain damage by restoring white matter
Figure 3 Effects of CP on hippocampal levels of inflammatory mediators in chronic BCCAo rats. (A) Representative western blot of COX-2,
IL-1β, and IL-6. (B) The levels of inflammatory mediators (COX-2, IL-1β, and IL-6) were increased in the BCCAo + Vehicle group (n = 8), compared
to the sham-control group (n = 8,*). CP administration (n = 8) attenuated the increased levels of hippocampal inflammatory mediators induced by
chronic BCCAo (#).
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viously reported that chronic cerebral hypoperfusion
induced by chronic BCCAo results in cognitive impair-
ments, microglial activation in the white matter, and phos-
phorylation of hippocampal MAPKs. Furthermore, we
showed that Fructus mume extract improves the cognitive
impairment induced by chronic cerebral hypoperfusion
[7]. Our previous studies and the present study indicate
that the BCCAo animal model is a well-established model
for examining the efficacies of drug candidates for the
treatment of VaD. The white matter constitutes approxi-
mately 50% of the human brain volume, and the hippo-
campus plays an important role in memory formation,
organization, and storage, which these regions are highly
vulnerable to chronic cerebral hypoperfusion [18]. Long-
term changes in regional cerebral blood flow and glucose
utilization in the white matter, including the corpusFigure 4 Effects of CP on increased levels of hippocampal phosphory
western blot of total MAPKs and phosphorylated MAPKs. (B) The hippocam
(p-JNK), were increased by chronic BCCAo (*). CP administration attenuated
chronic BCCAo (#). Each group had 8 subjects.callosum, internal capsule, and optic tract, of chronic
BCCAo rats have been reported [19], and it is subse-
quently involved in development of cognitive decline by
damage of the white matter [20,21]. A recent study de-
monstrated that white matter and hippocampal damage
are induced by the degradation of the myelin sheath, a
component of the white matter and hippocampus [15].
MBP is involved in the stability of the myelin sheath [15].
Therefore, MBP expression levels indicate the severity of
white matter and hippocampal damage. The present study
showed that MBP expression was decreased in the white
matter and hippocampus under chronic BCCAo, but the
decrease in MBP expression was not observed in the
BCCAo rats given CP treatments. In addition, MBP
expression did not reduced in cerebral cortex, one of
the grey matter regions (Additional file 2: Figure S2).
These results are supported by the finding that neuronallated MAPKs induced by chronic BCCAo. (A) Representative
pal levels of phosphorylated ERK (p-ERK) and p38 (p-p38), but not JNK
the increased levels of hippocampal p-ERK and p-p38 induced by
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rather than the grey matter in moderate cerebral hypo-
perfusion animal [22]. Furthermore, CP treatment de-
creases neuronal cell death in the hippocampus induced
by chronic BCCAo. These findings suggest that CP may
exert protective effects against white matter and hippo-
campal damage induced by chronic cerebral hypoper-
fusion via inhibition of myelin degradation and the
neuronal death.
Inflammation plays a key role in white matter lesions in-
duced by chronic cerebral hypoperfusion [23,24]. Based
on evidence of microglial activation and increased expres-
sion of proinflammatory mediators in chronic BCCAo
rats, neuroinflammation is associated with the induction
of white matter lesions following chronic cerebral hypo-
perfusion [10,25,26]. Microglia are a major source of pro-
inflammatory cytokines, such as tumor necrosis factor-α
(TNF-α) and IL-1β [16]. These cytokines initiate intracel-
lular signaling cascades, including MAPK and nuclear
factor-kappa B (NF-kB), by interacting with their immune
cell receptor, and subsequently exacerbate myelin degra-
dation [27,28]. MAPK signaling plays a major role in
synaptic plasticity and hippocampus-dependent memory
[29] and is involved in microglial activation and the
production of proinflammatory mediators [27]. Actually,
hyperphosphorylation of MAPKs and overproduction of
proinflammatory cytokines, such as IL-1β [8] and IL-6
[30], is observed in the brains of rats under chronic
BCCAo [7,31]. In addition, MAPK signaling is involved in
the upregulation of proinflammatory cytokines, including
TNF-α, IL-1β, and IL-6, in the hippocampus and micro-
glia. Blockade of MAPK signaling using a specific inhibitor
resulted in a reduction of the increased expression of pro-
inflammatory cytokines induced by a stimulator [32,33].
Therefore, many studies have suggested that the inhibition
of microglial activation and inflammatory responses might
contribute to the prevention of white matter and hippo-
campal lesions [20,34]. The present study showed that CP
inhibits MBP breakdown, microglial activation, the up-
regulation of proinflammatory mediators, and the hyper-
phosphorylation of MAPKs in the white matter and
hippocampus of rats under chronic BCCAo.Conclusion
We demonstrate that CP ameliorates white matter and
hippocampal damage induced via chronic cerebral hypo-
perfusion by attenuating the induction of white matter
lesions and the neuroinflammatory response. Further-
more, the suppression of the inflammatory response by
CP might be involved in the downregulation of MAPK
signaling. These findings suggest that CP may be a po-
tential candidate for the prevention and treatment of
AD and VaD.Additional files
Additional file 1: Figure S1. Experimental design.
Additional file 2: Figure S2. Effect of CP on damage of the grey
matter by chronic BCCAo. Immunohistological staining was performed to
assess the expression levels of MBP in cerebral cortex of grey matter in
the sham-control group (n=4), BCCAo+Vehicle group (n=6), and BCCAo+
CP group (n=7). (A) Representative photomicrograph of MBP-positive
cells. (B) Unlike apparent difference of MBP level in the hippocampus,
MBP levels in the cerebral cortex, an adjacent grey matter region to the
hippocampus, show no significant difference among the groups. CC,
cerebral cortex; CA 1, cornu ammonis 1.
Additional file 3: Figure S3. Effect of CP on the chronic BCCAo-
induced neuronal cell reduction in the hippocampus. Immunohistological
staining was accomplished to evaluate the NeuN-positive cells (neuronal
antibody) in CA1, CA3, and DG subfields of hippocampus in the sham-
control group (n=4), BCCAo+Vehicle group (n=6), and BCCAo+CP group
(n=7). (A) Representative photomicrograph of NeuN-positive cells. (B)
NeuN-positive cells were decreased in CA1, CA3, and DG subfields of the
chronic BCCAo rats compared to sham-operated control rats. Relative to
the chronic BCCAo rats given vehicle, the reduction of MBP expression in
the CP-treated chronic BCCAo rats was not observed. The statistical signif-
icances among these results were not observed. CA 1 and 3, cornu
ammonis 1 and 3; DG, dentate gyrus.
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